Literature DB >> 900676

Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections.

J G Kane, R H Parker, G W Jordan, P D Hoeprich.   

Abstract

The nafcillin concentration of simultaneous cerebrospinal fluid (CSF) and serum specimens from nine patients being treated with parenteral nafcillin for staphylococcal infection were measured. Marked variations in the ratio of CSF/serum nafcillin concentration were observed. However, the concentration of nafcillin in the CSF was greater than the minimum lethal concentration (MLC) for Staphylococcus aureus in eight of the nine patients. In five patients with CSF pleocytosis, the nafcillin concentration was three to 100 times the MLC. These results support the recommendation to use nafcillin in doses of at least 100 to 200 mg/kg body weight-day for treatment of meningitis caused by S. aureus.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 900676     DOI: 10.7326/0003-4819-87-3-309

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  7 in total

1.  Staphylococcus aureus meningitis: 26 years' experience at Vancouver General Hospital.

Authors:  F J Roberts; J A Smith; K R Wagner
Journal:  Can Med Assoc J       Date:  1983-06-15       Impact factor: 8.262

2.  New rapid assay for nafcillin in serum by spectrofluorometry.

Authors:  D M Lichtenwalner; B Suh; B Lorber; A M Sugar
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

3.  Penetrance of nafcillin into human ventricular fluid: correlation with ventricular pleocytosis and glucose levels.

Authors:  R Yogev; W E Schultz; S B Rosenman
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

Review 4.  Penicillins. A current review of their clinical pharmacology and therapeutic use.

Authors:  Dilip Nathwani; Martin J Wood
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

5.  Absence of nafcillin-associated nephritis. A prospective analysis of 210 patients.

Authors:  S L Barriere; J E Conte
Journal:  West J Med       Date:  1980-12

6.  Flucloxacillin treatment of Staphylococcus aureus meningitis.

Authors:  S R Ritchie; P Rupali; S A Roberts; M G Thomas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-07       Impact factor: 5.103

7.  Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill Patients.

Authors:  Alison R Novak; Martin Krsak; Tyree H Kiser; Robert T Neumann; Luis Cava Prado; Kyle C Molina; Scott W Mueller
Journal:  Open Forum Infect Dis       Date:  2021-12-25       Impact factor: 3.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.